13F-HR filed by ENAVATE SCIENCES GP, LLC
ENAVATE SCIENCES GP, LLC filed this 13F-HR for the quarter ended 2025-12-31, filed 2026-02-17, with 7 holding rows worth $506,782,253.
- Accession
- 0001953107-26-000003
- Filer
- CIK 1953107
- Filed
- 2026-02-17
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2025
A holdings report, 7 entries on the cover page, a total value of $506,782,253 stated on the cover page (in dollars after the unit check, H1), rows summing to $506,782,253 with VALUE read as dollars as filed, 13F file number 028-25306. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ZENAS BIOPHARMA INC COM | 98937L105 | Stock | 3,919,159 | $142,304,663 | dollars as filed | |
| IMMUNOME INC | 45257U108 | COM | 4,768,583 | $102,429,163 | dollars as filed | |
| SIONNA THERAPEUTICS INC | 829401108 | COMMON STOCK | 2,478,030 | $101,946,154 | dollars as filed | |
| UPSTREAM BIO INC | 91678A107 | COMMON STOCK | 2,459,703 | $66,780,936 | dollars as filed | |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 7,788,150 | $41,822,366 | dollars as filed | |
| BRIDGEBIO ONCOLOGY THERAPEUT | 107924102 | COM NEW | 2,626,946 | $32,889,364 | dollars as filed | |
| CAMP4 THERAPEUTICS CORP | 13463J101 | COM | 3,035,825 | $18,609,607 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001953107-26-000003 | this filing | 2026-02-17 | acceptance time not in the bulk data set |